
Paulson & Co. Inc.
About Paulson & Co. Inc.’s 13F portfolio
Paulson & Co. Inc. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Paulson & Co. Inc. reported $2.6B across 8 US-listed positions (). Its largest position is MADRIGAL PHARMACEUTICALS INC (MDGL) at 28% of the reported book, and its ten biggest holdings make up 100% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: MDGL MADRIGAL PHARMACEUTICALS INC | $396.74 −0.34% | 28% | 1.3M | $719.5M |
| 2 | NASDAQ: PPTA PERPETUA RESOURCES CORP | $15.47 −8.05% | 26% | 32.3M | $671.5M |
| 3 | NYSE: AAMI ACADIAN ASSET MANAGEMENT INC | $84.41 −4.23% | 16% | 5.8M | $417.9M |
| 4 | NYSE: BHC BAUSCH HEALTH COS INC | $8.56 −1.95% | 14% | 73.3M | $361.2M |
| 5 | NYSE American: THM INTERNATIONAL TOWER HILL MIN | $1.23 +0.82% | 8.1% | 104.5M | $207.9M |
| 6 | NYSE American: NG NOVAGOLD RESOURCES INC | $4.81 −9.42% | 6.3% | 27.2M | $162.6M |
| 7 | NASDAQ: THRY THRYV HLDGS INC | $0.69 −12.13% | 1.3% | 8.4M | $33.3M |
| 8 | NASDAQ: GOOGL ALPHABET INC | $272.66 −3.46% | 0.1% | 5K | $1.8M |
Showing the 8 largest positions reported in this 13F.
- Healthcare42%
- Basic Materials40%
- Financial Services16%
- Technology1.3%
- Communication Services0.1%
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | THM INTERNATIONAL TOWER HILL MINES LTD | 13D | 39.9% · 2 classes | 104.5M | Filed 20 APR 2026 |
| 2 | PPTA Perpetua Resources Corp. | 13D | 31.2% | 32.3M | Filed 16 JUN 2025 |
| 3 | AAMI Acadian Asset Management Inc. | 13D | 21.6% · 2 classes | 7.7M | Filed 05 SEP 2025 |
| 4 | THRY Thryv Holdings, Inc. | 13G | 19.1% | 8.4M | Filed 03 MAR 2026 |
| 5 | BHC Bausch Health Companies Inc. | 13D | 19.1% | 70.8M | Filed 14 AUG 2025 |
| 6 | NG NOVAGOLD RESOURCES INC | 13G | 9.8% | 40.0M | Filed 14 AUG 2025 |
| 7 | MDGL Madrigal Pharmaceuticals, Inc. | 13G | 7.5% · 2 classes | 1.7M | Filed 17 FEB 2026 |
Showing all 7 disclosed stakes. 4 last disclosed over a year ago (the holder may since have dropped below 5%).
Reading Paulson & Co. Inc.’s 13F portfolio
Paulson & Co. Inc.’s $2.6B 13F book is spread across 8 reported positions and is highly concentrated — its ten largest positions alone are 100% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are MDGL, PPTA, AAMI, BHC and THM, led by MADRIGAL PHARMACEUTICALS INC (MDGL) at 28% of the portfolio. The heaviest sector exposure is Healthcare (42%), then Basic Materials (40%).
What a 13F does and doesn’t reveal
A 13F captures only Paulson & Co. Inc.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Paulson & Co. Inc. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Paulson & Co. Inc.'s profile on this page is built directly from those filings.
How current is the 13F data on Paulson & Co. Inc.'s page?
It reflects Paulson & Co. Inc.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Paulson & Co. Inc. files its next quarterly report, this page refreshes automatically.
Can I see Paulson & Co. Inc.'s complete list of holdings?
This page highlights Paulson & Co. Inc.'s largest positions rather than all 8 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Paulson & Co. Inc.'s filings.
Does a 13F show everything Paulson & Co. Inc. owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Paulson & Co. Inc.'s book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Paulson & Co. Inc. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

